Companies: 10,795·Total market cap: $144.5T
LianBio

LianBio

LIANYOTCHealthcare● Active
$0.11
+$0.00(+0.00%)
Market Cap$12025709
P/E Ratio
52W High$0.439
52W Low$0.03
Overview

LianBio (LIANY) Revenue

Annual & quarterly revenue history · segment & region breakdown

LIANY · revenue · updated Jun 10, 2026

Core revenue metrics

LianBio trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
163 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · LianBio SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
LIANY revenue by year · LIANY revenue history · LIANY annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income LianBio receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

LianBio reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from LianBio's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

LIANY revenue · 4 questions

LIANY's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

LIANY revenueLIANY annual revenuewhat is LIANY revenueLIANY TTM revenue

Source: FMP · LianBio SEC filings · GAAP · LianBio SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026